Salbutamol 2mg tablets

Երկիր: Միացյալ Թագավորություն

Լեզու: անգլերեն

Աղբյուրը: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ակտիվ բաղադրիչ:

Salbutamol sulfate

Հասանելի է:

Approved Prescription Services Ltd

ATC կոդը:

R03CC02

INN (Միջազգային անվանումը):

Salbutamol sulfate

Դոզան:

2mg

Դեղագործական ձեւ:

Oral tablet

Կառավարման երթուղին:

Oral

Դաս:

No Controlled Drug Status

Ռեկվիզորի տեսակը:

Valid as a prescribable product

Ապրանքի ամփոփագիր:

BNF: 03010101

Տեղեկատվական թերթիկ

10mm
text free
to right of
pharmacode
10mm
text free
to left of
pharmacode
Pharmacode
Area
(12 x 20mm)
10mm
Bleed off
by 2mm
at bottom
of page
30x115mm 18pp label leaflet Profile (BST)
BATCH & 2D CODING AREA
PRINT FREE
DO NOT REMOVE THIS PANEL
* Please note that ONLY Artwork Studio is permitted to make changes to
the above artwork.
No changes are permitted by any 3rd party other than added notes and
mark ups for required changes.
approved for print/date
PROOF ROUND
[e-mail]
Technical
Approval
NON PRINTING COLOURS
COLOURS
DATE SENT:
DATE RECEIVED:
Item number:
ORIGINATOR:
ORIGINATION DATE:
REVISION DATE:
REVISED BY:
DIMENSIONS:
MIN BODY TEXT SIZE:
SUPPLIER:
1.
2.
3.
4.
5.
6.
1.
2.
3.
4.
5.
FMD info
NA (not a carton)

No

Yes

Details
________________________________________________________________________________________
Version 2
01.11.2017
SALBUTAMOL 2MG 28 TABLETS LABEL LEAFLET - UK
04
Black
R.Paul
25.07.2019
06-08-19
RH
BBBA5633
30 x 115
7pts
Accord Barnstaple
n/a
n/a
Profile
Braille
Print Free Areas
FMD
PRINT
FREE
Print free areas required
for FMD.
PRINT FREE AREAS
50973994 BBBA5633
50973994 BBBA5633
5
0 1 2 6 1 7
0 0 8 9 2 3
TABLETS
SALBUTAMOL
2
MG
_28 TABLETS_
_For oral use_
Each tablet contains 2.4mg salbutamol
sulfate equivalent to2mg salbutamol.
For oral administration. Also contains lactose,
E122-see leaflet for details. Use as directed by physician.
Keep out of the sight and reach of children.
Read the package leaflet before use.
Store below 25°C in a dry place.
PL 0142/0485
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on
to others. It may harm
them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or pharmacist.
This includes any pos

Ապրանքի հատկությունները

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Salbutamol Tablets BP 2mg
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 2.4mg salbutamol sulfate equivalent to 2mg
salbutamol.
Excipients with known effect:
Each 2mg tablet contains:
-
60.05mg Lactose monohydrate
-
Carmoisine (E122)
For the full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Tablets for oral administration.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Salbutamol Tablets are indicated in adults, adolescents and children
aged 2 to
12 years.
1. For the relief of bronchospasm in bronchial asthmas of all types.
2. Chronic bronchitis.
3. Emphysema.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_ _
_Adults:_
The usual effective dose is 4mg three or four times per day. If
adequate
bronchodilation is not obtained each single dose may be gradually
increased to
as much as 8mg. However, it has been established that some patients
obtain
adequate relief with 2mg three or four times daily. In elderly
patients or in
those known to be unusually sensitive to beta-adrenergic stimulant
drugs, it is
advisable to initiate treatment with 2mg three or four times per day.
_ _
_Children:_
The following doses should be administered three or four times daily.
2-6 years: 1-2mg
6-12 years: 2mg
Over 12 years: 2-4mg
The product is not recommended for children under 2 years of age. The
drug
is well tolerated by children so that, if necessary, these doses may
be
cautiously increased.
Method of administration
For oral use.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients
listed in
section 6.1.
Salbutamol should not be used for threatened abortion during the first
or
second trimester of pregnancy.
Salbutamol and beta-blocking drugs such as propranolol should not
usually be
prescribed together.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Bronchodilators should not be the only or main treatment in patients
with
severe or unstable asthma.
Increasing use of bronchodilators in particular s